Join
Live feed
·
INSIDERFilingvia Quantisnow
Supernus Pharmaceuticals Inc. logo

President, CEO Khattar Jack A. converted options into 39,320 shares and covered exercise/tax liability with 15,325 shares, increasing direct ownership by 2% to 1,185,228 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SUPN· Supernus Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SUPN (Supernus Pharmaceuticals Inc.) and more on Quantisnow.